Total Payments
$20,738
2024 Payments
$3,171
Companies
38
Transactions
954
Medicare Patients
2,093
Medicare Billing
$842,574
Payment Breakdown by Category
Food & Beverage$20,574 (99.2%)
Education$164.44 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,574 | 946 | 99.2% |
| Education | $164.44 | 8 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,905 | 83 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,881 | 78 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,673 | 85 | $0 (2024) |
| Alkermes, Inc. | $1,662 | 45 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,608 | 55 | $0 (2024) |
| Lundbeck LLC | $1,351 | 71 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $1,212 | 45 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,099 | 64 | $0 (2022) |
| ITI, Inc. | $1,005 | 40 | $0 (2023) |
| Allergan, Inc. | $880.30 | 47 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,171 | 118 | Alkermes, Inc. ($499.51) |
| 2023 | $3,000 | 119 | Teva Pharmaceuticals USA, Inc. ($499.81) |
| 2022 | $2,943 | 132 | Alkermes, Inc. ($523.59) |
| 2021 | $3,047 | 154 | Takeda Pharmaceuticals U.S.A., Inc. ($658.87) |
| 2020 | $1,750 | 82 | Takeda Pharmaceuticals U.S.A., Inc. ($288.34) |
| 2019 | $2,374 | 114 | Neurocrine Biosciences, Inc. ($445.05) |
| 2018 | $2,953 | 145 | Sunovion Pharmaceuticals Inc. ($587.89) |
| 2017 | $1,499 | 90 | Allergan Inc. ($263.46) |
All Payment Transactions
954 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Neuropsychiatry | ||||||
| 12/17/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.20 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.34 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $29.69 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $124.77 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Central Nervous System | ||||||
| 12/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/02/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/22/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $5.92 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/21/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $29.09 | General |
| Category: CNS | ||||||
| 11/21/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Neuropsychiatry | ||||||
| 11/19/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Neurology | ||||||
| 11/18/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $8.06 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $14.45 | General |
| 11/13/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $30.08 | General |
| Category: Neuropsychiatry | ||||||
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Central Nervous System | ||||||
| 11/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.98 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 540 | 1,999 | $685,014 | $214,485 |
| 2022 | 7 | 462 | 1,423 | $350,750 | $128,634 |
| 2021 | 9 | 525 | 1,945 | $622,005 | $221,365 |
| 2020 | 7 | 566 | 2,700 | $894,260 | $278,090 |
Total Patients
2,093
Total Services
8,067
Medicare Billing
$842,574
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 166 | 714 | $219,740 | $79,495 | 36.2% |
| 90868 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | Office | 2023 | 13 | 388 | $232,800 | $66,762 | 28.7% |
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 23 | 233 | $116,500 | $29,780 | 25.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 85 | 197 | $29,824 | $11,698 | 39.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 52 | $23,929 | $8,260 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 99 | $22,465 | $7,457 | 33.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 32 | 32 | $18,011 | $6,543 | 36.3% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 19 | 33 | $8,350 | $2,580 | 30.9% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 115 | 233 | $11,650 | $1,064 | 9.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 18 | $1,745 | $847.04 | 48.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 154 | 736 | $220,800 | $82,614 | 37.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 24 | 118 | $53,100 | $19,363 | 36.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 82 | 188 | $28,200 | $11,704 | 41.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 106 | $23,850 | $8,067 | 33.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 23 | 23 | $11,500 | $4,703 | 40.9% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 109 | 232 | $11,600 | $1,101 | 9.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 18 | 20 | $1,700 | $1,081 | 63.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 162 | 748 | $224,400 | $88,734 | 39.5% |
| 90868 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), subsequent delivery and management, per session | Office | 2021 | 12 | 357 | $214,200 | $62,934 | 29.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 131 | 287 | $64,575 | $22,850 | 35.4% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 117 | 348 | $52,200 | $21,891 | 41.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 36 | 94 | $42,300 | $16,324 | 38.6% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 13 | 55 | $13,750 | $4,464 | 32.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 16 | 16 | $7,950 | $3,078 | 38.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 18 | 18 | $1,530 | $976.68 | 63.8% |
About Dr. Rena Ferguson, MD
Dr. Rena Ferguson, MD is a Psychiatry healthcare provider based in Port Jefferson, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013082452.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rena Ferguson, MD has received a total of $20,738 in payments from pharmaceutical and medical device companies, with $3,171 received in 2024. These payments were reported across 954 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($20,574).
As a Medicare-enrolled provider, Ferguson has provided services to 2,093 Medicare beneficiaries, totaling 8,067 services with total Medicare billing of $842,574. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Port Jefferson, NY
- Active Since 11/21/2006
- Last Updated 01/27/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1013082452
Products in Payments
- REXULTI (Drug) $1,992
- VRAYLAR (Drug) $1,604
- TRINTELLIX (Drug) $1,479
- CAPLYTA (Drug) $1,360
- INGREZZA (Drug) $1,212
- LATUDA (Drug) $1,099
- ARISTADA (Drug) $1,081
- AUSTEDO (Drug) $1,065
- ABILIFY MAINTENA (Drug) $925.76
- SPRAVATO (Drug) $889.56
- INVEGA SUSTENNA (Drug) $696.44
- Austedo XR (Drug) $578.35
- HETLIOZ (Drug) $557.47
- VYVANSE (Drug) $471.96
- Trintellix (Drug) $469.04
- LYBALVI (Drug) $455.95
- BELSOMRA (Drug) $302.62
- JORNAY PM (Drug) $301.49
- APLENZIN (Drug) $256.22
- Dayvigo (Drug) $241.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Port Jefferson
Jon-Kar Zubieta, Md,Phd, MD,PHD
Psychiatry — Payments: $59,343
Psychiatry $59,343
Sameh Wahba, M.d, M.D
Psychiatry — Payments: $46,212
Psychiatry $46,212
George Fairey, Md, MD
Psychiatry — Payments: $8,973
Psychiatry $8,973
Dr. Marta Maczaj, M.d, M.D
Psychiatry — Payments: $2,583
Psychiatry $2,583
Jenna Taglienti, Md, MD
Psychiatry — Payments: $2,174
Psychiatry $2,174
Dr. Michael Destefano, M.d, M.D
Psychiatry — Payments: $1,086
Psychiatry $1,086